Release Date: 12/07/23 09:34 Summary: Suspension following appointment of administrators Price Sensitive: Yes Download Document 86.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%